Role of Advanced Glycation End Products in Intervertebral Disc Degeneration: Mechanism and Therapeutic Potential

Oxid Med Cell Longev. 2022 Dec 17:2022:7299005. doi: 10.1155/2022/7299005. eCollection 2022.

Abstract

The incidence of low back pain caused by lumbar disc degeneration is high, and it can lead to loss of work ability and impose heavy social and economic burdens. The pathogenesis of low back pain is unclear, and there are no effective treatments. With age, the deposition of advanced glycation end products (AGEs) in intervertebral disc (IVD) gradually increases and is accelerated by diabetes and a high-AGEs diet, leading to destruction of the annulus fibrosus (AF), nucleus pulposus (NP), and cartilage endplate (CEP) and finally intervertebral disc degeneration (IDD). Reducing the accumulation of AGEs in IVD and blocking the transmission of downstream signals caused by AGEs have a significant effect on alleviating IDD. In this review, we summarize the mechanism by which AGEs induce IDD and potential treatment strategies.

Publication types

  • Review

MeSH terms

  • Annulus Fibrosus* / pathology
  • Glycation End Products, Advanced
  • Humans
  • Intervertebral Disc Degeneration* / pathology
  • Intervertebral Disc* / pathology
  • Low Back Pain* / pathology

Substances

  • Glycation End Products, Advanced